Cancer Prevention Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2023-03-21 ms6000000441903562 来自四川省

当天就under review了，希望能中啊啊

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2022-10-31 longtengfei811

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2022-6-18投稿
2022-6-21送外审
2022-7-21第一审稿意见
2022-9-8第一次修回
2022-9-14外审
2022-10-6小修+初步接收
2022-10-11第二次修回
2022-10-21外审
2022-10-21正式接收
编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。

32 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

摘要和HIGHLIGHTS的区别？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2021-12-29 衣谷

摘要一定要描述使用的方法么？

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2020-05-21 ms8838453850558450

审稿速度:1.0
经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。

108 0

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2020-05-14 ms7933220824164544

审稿速度:1.0
经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评

108 0

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2019-08-03 wangcxzf

请问一审几个月呀sunliang 2019-04-05 00:00:00 发表:
没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的

sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的

157 0

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2019-04-05 sunliang

没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的

175 0

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2019-01-22 ms2998163265174406

肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2120859, encodeId=627f2120859eb, content=当天就under review了，希望能中啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18c35635472, createdName=ms6000000441903562, createdTime=Tue Mar 21 19:53:45 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2097667, encodeId=9168209e6674a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2022-6-18投稿 2022-6-21送外审 2022-7-21第一审稿意见 2022-9-8第一次修回 2022-9-14外审 2022-10-6小修+初步接收 2022-10-11第二次修回 2022-10-21外审 2022-10-21正式接收 编辑非常友好版面费=基础费用900+表图250*6+公开发表2300=4700美元，如果不想公开发表，可以省2300美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e01597331, createdName=longtengfei811, createdTime=Mon Oct 31 20:06:41 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101297, encodeId=eea9110129ec5, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101298, encodeId=c543110129831, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860798, encodeId=c94b860e98e1, content=审稿速度:1.0 经验分享：半个月审稿意见返回，效率很快。尽管最后没有被录用，但是提出了很多中肯的意见。挺好的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu May 21 08:20:13 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860534, encodeId=a66086053450, content=审稿速度:1.0 经验分享：4月19号投，4月21号under review，5月4日投稿意见返回。尽管没有被录取，但提出了很多中肯意见。速度快，效率高，好评 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Thu May 14 08:21:11 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574361, encodeId=1af15e436199, content=请问一审几个月呀sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=sunliang 2019-04-05 00:00:00 发表: 没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epHuy1OOTMw71icutvL21Nr2UUZ3wf7mN2c1tTicwF0urO4ia6BNZg5zUUhcjpMr2o1OHXn465N4vuYQ/132, createdBy=78c72021094, createdName=wangcxzf, createdTime=Sat Aug 03 00:00:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569170, encodeId=74295691e0b5, content=没人关注这个杂志吗？这个杂志是AACR旗下的杂志，还是非常不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849424, encodeId=8efc84942450, content=肿瘤学期刊中属于还是比较不错的期刊，审稿人给的意见也很细。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5d55414009, createdName=ms2998163265174406, createdTime=Tue Jan 22 15:57:45 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509200, encodeId=f31c5092001f, content=投了一篇中药抗肿瘤很快就接受了！没有补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jan 17 19:01:00 CST 2015, time=2015-01-17, status=1, ipAttribution=)]

2015-01-17 匿名用户

投了一篇中药抗肿瘤很快就接受了！没有补实验

438 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务